Ono Pharmaceutical Co (MEX:4528N) FCF Yield %: 7.48 (As of Jun. 29, 2026) — 93% Above Median


MEX:4528N Ono Pharmaceutical Co Ltd MEX:4528N
88 GF Score
Price MXN341.69
GF Value MXN324.16
! 2 Warning Signs
View Full Analysis

What is Ono Pharmaceutical Co FCF Yield %?

Ono Pharmaceutical Co MEX:4528N 88 FCF Yield % is 7.48 as of Jun. 29, 2026, which is 93% above its 10-year median of 3.87. GuruFocus rates MEX:4528N with a GF Score™ of 88/100 and a GF Value™ of MXN324.16. The stock has 2 warning signs investors should review. Among 1,001 Drug Manufacturers companies, Ono Pharmaceutical Co ranks better than 82.22% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Ono Pharmaceutical Co's Trailing 12-Month Free Cash Flow is MXN9,236 Mil, and Market Cap is MXN120,951 Mil. Therefore, Ono Pharmaceutical Co's FCF Yield % for today is 7.48%.

The historical rank and industry rank for Ono Pharmaceutical Co's FCF Yield % or its related term are showing as below:

MEX:4528N' s FCF Yield % Range Over the Past 10 Years
Min: -1.1   Med: 3.87   Max: 12.19
Current: 7.48


During the past 13 years, the highest FCF Yield % of Ono Pharmaceutical Co was 12.19%. The lowest was -1.10%. And the median was 3.87%.

MEX:4528N's FCF Yield % is ranked better than
82.22% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 0.64 vs MEX:4528N: 7.48

Ono Pharmaceutical Co's FCF Margin % for the quarter that ended in Mar. 2026 was 41.13%.


Ono Pharmaceutical Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Ono Pharmaceutical Co FCF Yield % Related Terms


Ono Pharmaceutical Co FCF Yield % Historical Data

* Premium members only.

The historical data trend for Ono Pharmaceutical Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ono Pharmaceutical Co FCF Yield % Chart

Ono Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.27 7.69 6.20 6.37 5.91

Ono Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.79 -14.51 15.21 8.68 13.83

MEX:4528N vs LLY, JNJ, ABBV: FCF Yield % Comparison

For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ono Pharmaceutical Co FCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Ono Pharmaceutical Co's FCF Yield % falls into.


MEX:4528N
88GF Score
Ono Pharmaceutical Co Ltd MEX:4528N
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ono Pharmaceutical Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Ono Pharmaceutical Co's FCF Yield % for the fiscal year that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=9494.735 / 160562.52283
=5.91%

Ono Pharmaceutical Co's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=5550.291 * 4 / 160562.52283
=13.83%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 7.48 mean?
Ono Pharmaceutical Co (MEX:4528N) has a FCF Yield % of 7.48 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ono Pharmaceutical Co and its competitors. This is 93% above median its historical median of 3.87. According to the industry distribution chart, Ono Pharmaceutical Co ranks #178 out of 1001 companies in the Drug Manufacturers industry, placing it in the top 17.8%.
Is Ono Pharmaceutical Co's FCF Yield % too high?
Ono Pharmaceutical Co's current FCF Yield % of 7.48 is 93% above median its 10-year median of 3.87. The Drug Manufacturers industry median FCF Yield % is 0.64. Ono Pharmaceutical Co's value of 7.48 is 1068.8% above this industry median. Based on the distribution chart, Ono Pharmaceutical Co ranks #178 out of 1001 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Ono Pharmaceutical Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's FCF Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Ono Pharmaceutical Co ranks #178 out of 1001 companies for FCF Yield %. This places Ono Pharmaceutical Co in the top 18% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 0.64. Ono Pharmaceutical Co's value of 7.48 is 1068.8% above this benchmark. While the company's 10-year median is 3.87 vs. the industry median of 0.64, Ono Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.64, based on 1,001 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ono Pharmaceutical Co's current FCF Yield % of 7.48 is 1068.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ono Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ono Pharmaceutical Co's current FCF Yield % is 7.48, which is 93% above median its own 10-year median of 3.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Ono Pharmaceutical Co (MEX:4528N) has a current FCF Yield % of 7.48. The stock's GF Value™ is MXN324.16, compared to a current price of MXN341.69 — trading 5.4% above its estimated fair value. The current FCF Yield % is 7.48, which is 93% above median its 10-year median of 3.87 and 1068.8% above the Drug Manufacturers industry median of 0.64. Ono Pharmaceutical Co's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Ono Pharmaceutical Co (MEX:4528N), the current FCF Yield % is 7.48 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ono Pharmaceutical Co (MEX:4528N) Overvalued in 2026?

Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued. The current stock price of MXN341.69 is trading 5.4% above its estimated GF Value™ of MXN324.16.

Key valuation signals for MEX:4528N:

  • FCF Yield %: 7.48 (93% above median its 10-year median of 3.87)
  • GF Value™: MXN324.16 vs. price of MXN341.69 (5.4% above fair value)
  • GF Score™: 88/100 with 2 warning signs
  • Industry Position: 1068.8% above the Drug Manufacturers median (#178 of 1001)

No single metric tells the full story. See the MEX:4528N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ono Pharmaceutical Co Business Description

Address 1-8-2 Kyutarocho, Chuo-ku, Osaka, JPN, 541-8564
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
88GF Score

Get the complete analysis for MEX:4528N

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN341.69
Price
MXN324.16
GF Value